Carsten Tschöpe

Active 2000–2025

205
Papers
37,223
Citations
94
h-index
201
i10-index

Citations

Citations per year for Carsten Tschöpe1911: 1 citations1996: 1 citations2001: 4 citations2002: 3 citations2003: 3 citations2004: 14 citations2005: 17 citations2006: 28 citations2007: 47 citations2008: 98 citations2009: 159 citations2010: 185 citations2011: 186 citations2012: 182 citations2013: 176 citations2014: 288 citations2015: 221 citations2016: 286 citations2017: 344 citations2018: 297 citations2019: 1,147 citations2020: 1,559 citations2021: 1,741 citations2022: 1,458 citations2023: 1,070 citations2024: 1,852 citations2025: 979 citations2026: 33 citations1912–1995: no citations, so these years are not shown1997–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,224 citing papers, 19.2% of this breakdownGermany: 1,419 citing papers, 8.4% of this breakdownChina: 1,364 citing papers, 8.1% of this breakdownItaly: 1,266 citing papers, 7.5% of this breakdownUnited Kingdom: 1,090 citing papers, 6.5% of this breakdownNetherlands: 727 citing papers, 4.3% of this breakdownCanada: 554 citing papers, 3.3% of this breakdownJapan: 534 citing papers, 3.2% of this breakdownFrance: 508 citing papers, 3% of this breakdownSpain: 444 citing papers, 2.6% of this breakdownAustralia: 397 citing papers, 2.4% of this breakdownSwitzerland: 349 citing papers, 2.1% of this breakdown
0%19.2%Other 29.4%

Fields

  • Medicine81.1%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Immunology and Microbiology2.8%
  • Engineering2%
  • Neuroscience0.6%
  • Nursing0.4%
  • Other1.3%

Topics

  • Cardiovascular Function and Risk Factors10.9%
  • Heart Failure Treatment and Management5.9%
  • Cardiac Fibrosis and Remodeling4%
  • Cardiac Imaging and Diagnostics3.2%
  • Viral Infections and Immunology Research3%
  • Cardiomyopathy and Myosin Studies2%
  • Other71%

Coauthors

All papers

Open in search
  1. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

    Authors: , - Journal of the American College of Cardiology 2013 cited by 3,438

  2. How to Diagnose Heart Failure with Preserved Ejection Fraction: The HFA–PEFF Diagnostic Algorithm: A Consensus Recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2019 cited by 1,785

  3. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

    Authors: , , , , , , , , , , , , , , , , , , - Nature Reviews Cardiology 2020 cited by 1,183

  4. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , - Circulation Heart Failure 2020 cited by 778

  5. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raimund Erbel, Alessandro Cuneo, Karl Heinz Kuck, Claudius Jacobshagen, Gerd Hasenfuß, Mahir Karakas, Wolfgang Köenig, Wolfgang Rottbauer, Samir M. Said, Ruediger C. Braun‐Dullaeus, Florim Cuculi, Adrian Banning, Thomas Fischer, Tuija Vasankari, Juhani Airaksinen, Marcin Fijałkowski, Andrzej Rynkiewicz, Maciej Pawlak, Grzegorz Opolski, Rafał Dworakowski, Philip MacCarthy, Christoph Kaiser, Stefan Osswald, Leonarda Galiuto, Filippo Crea, Wolfgang Dichtl, Wolfgang M. Franz, Klaus Empen, Stephan B. Felix, Clément Delmas, Olivier Lairez, Paul Erné, Jeroen J. Bax, Ian Ford, Frank Ruschitzka, Abhiram Prasad, Thomas F. Lüscher - New England Journal of Medicine 2015 cited by 2,533

  6. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2020 cited by 316

  7. Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aldo P. Maggioni, Frank Ruschitzka, John J.V. McMurray - European Journal of Heart Failure 2018 cited by 716

  8. Crosstalk between fibroblasts and inflammatory cells

    Authors: , , - Cardiovascular Research 2014 cited by 553

  9. Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

    Authors: , , , , , , , , , , , , - Circulation Heart Failure 2010 cited by 625

  10. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , - JACC Heart Failure 2015 cited by 582

  11. Cardiac fibroblasts and mechanosensation in heart development, health and disease

    Authors: , , , , , , , , - Nature Reviews Cardiology 2022 cited by 135

  12. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2021 cited by 216

  13. Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konstantinos Tsioufis, Antoni Bayés‐Genís, Ovidiu Chioncel, Felicita Andreotti, Enrico Agabiti‐Rosei, José Luís Merino, Marco Metra, Andrew J.S. Coats, Giuseppe Rosano - European Journal of Heart Failure 2023 cited by 187

  14. Inflammation – Cause or Consequence of Heart Failure or Both?

    Authors: , - Current Heart Failure Reports 2017 cited by 461

  15. Potential Usefulness and Clinical Relevance of Adding Left Atrial Strain to Left Atrial Volume Index in the Detection of Left Ventricular Diastolic Dysfunction

    Authors: , , , , , , , , , , , , , , , , - JACC. Cardiovascular imaging 2017 cited by 391

  16. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2013 cited by 738

  17. Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Ruschitzka, Jelena Čelutkienė, Tiny Jaarsma, Christian Mueller, Brenda Moura, Loreena Hill, Maurizio Volterrani, Yu. M. Lopatin, Marco Metra, Johannes Backs, Wilfried Müllens, Ovidiu Chioncel, Rudolf A. de Boer, Stefan D. Anker, Claudio Rapezzi, Andrew J.S. Coats, Carsten Tschöpe - European Journal of Heart Failure 2019 cited by 377

  18. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches

    Authors: , , , - The Lancet 2023 cited by 223

  19. Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2022 cited by 167

  20. Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 cited by 294

  21. Management of Myocarditis-Related Cardiomyopathy in Adults

    Authors: , , , - Circulation Research 2019 cited by 280

  22. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)

    Authors: , , , , , , , - European Heart Journal 2012 cited by 647

  23. Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

    Authors: , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2022 cited by 152

  24. Long-Term Prognosis of Patients With Takotsubo Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hölger Thiele, Johann Bauersachs, Carsten Tschöpe, Burkert Pieske, Lawrence Rajan, Guido Michels, Roman Pfister, Alessandro Cuneo, Claudius Jacobshagen, Gerd Hasenfuß, Mahir Karakas, Wolfgang Köenig, Wolfgang Rottbauer, Samir M. Said, Ruediger C. Braun‐Dullaeus, Adrian Banning, Florim Cuculi, Richard Kobza, Thomas Fischer, Tuija Vasankari, Juhani Airaksinen, Grzegorz Opolski, Rafał Dworakowski, Philip MacCarthy, Christoph Kaiser, Stefan Osswald, Leonarda Galiuto, Filippo Crea, Wolfgang Dichtl, Klaus Empen, Stephan B. Felix, Clément Delmas, Olivier Lairez, Ibrahim El‐Battrawy, İbrahim Akın, Martin Borggrefe, John D. Horowitz, Martin Kozel, Petr Toušek, Petr Widimský, Ekaterina Gilyarova, Alexandra Shilova, Mikhail Gilyarov, David E. Winchester, Christian Ukena, Jeroen J. Bax, Abhiram Prasad, Michael Böhm, Thomas F. Lüscher, Frank Ruschitzka, Christian Templin - Journal of the American College of Cardiology 2018 cited by 353